CRUK RadNet spans four leading central London institutes: UCL, King’s, Barts and the Crick, and unites multi-disciplinary expertise across London to cultivate a modernised radiatiation landscape.
![RadNet City of London](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/large_image/public/radnet_col.jpg?itok=8i8sO4D2)
Our research focus is predicated on the view that cancer cure by radiotherapy can be improved by concentrating on the following themes:
- Radiation Resistance Including cancer evolution and cancer stem cells
- Radiation Combinations How the TME and immune system affect response to radiotherapy
- Targeting and Technology Advanced radiotherapy techniques, including PBT, that converge on the tumour for children and young people’s cancers
- Outcomes and risk predictions Personalising radiotherapy using artificial intelligence, computational models and improved tumour imaging.
- Clinical translation Establish a clinical trials platform, to ensure a strong forward and reverse translational element to the above themes
News and features
UCLH proton beam therapy centre treats first patients
![UCLH Proton Bean gantry](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/small_image/public/gantry_uclh_signpost.jpeg?itok=IIfUfYUF)
One of only two NHS proton beam centres in the UK, the new centre at UCLH brings together some of the world’s leading specialists in complex cancers and will drive forward research into what remains a relatively new treatment.